List of Tables
    Table 1. Pneumonia Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Pneumonia Vaccine Market Trends
    Table 3. Pneumonia Vaccine Market Drivers
    Table 4. Pneumonia Vaccine Market Challenges
    Table 5. Pneumonia Vaccine Market Restraints
    Table 6. Global Pneumonia Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pneumonia Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pneumonia Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pneumonia Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pneumonia Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pneumonia Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Pneumonia Vaccine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Pneumonia Vaccine Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Pneumonia Vaccine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Pneumonia Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2021)
    Table 18. Top Players of Pneumonia Vaccine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Pneumonia Vaccine Product Type
    Table 20. Date of International Manufacturers Enter into Pneumonia Vaccine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Pneumonia Vaccine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Pneumonia Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Pneumonia Vaccine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Pneumonia Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Pneumonia Vaccine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Pneumonia Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Pneumonia Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Pneumonia Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Pneumonia Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Pneumonia Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Pneumonia Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Pneumonia Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Inc. Corporation Information
    Table 43. Pfizer Inc. Description and Business Overview
    Table 44. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. Pfizer Inc. Pneumonia Vaccine Product
    Table 46. Pfizer Inc. Recent Development
    Table 47. Glaxosmithkline Plc. Corporation Information
    Table 48. Glaxosmithkline Plc. Description and Business Overview
    Table 49. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. Glaxosmithkline Plc. Product
    Table 51. Glaxosmithkline Plc. Recent Development
    Table 52. Merck & Co., Inc. Corporation Information
    Table 53. Merck & Co., Inc. Description and Business Overview
    Table 54. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Merck & Co., Inc. Product
    Table 56. Merck & Co., Inc. Recent Development
    Table 57. Sanofi Pasteur Corporation Information
    Table 58. Sanofi Pasteur Description and Business Overview
    Table 59. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. Sanofi Pasteur Product
    Table 61. Sanofi Pasteur Recent Development
    Table 62. Serum Institute of India Pvt. Ltd. Corporation Information
    Table 63. Serum Institute of India Pvt. Ltd. Description and Business Overview
    Table 64. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Serum Institute of India Pvt. Ltd. Product
    Table 66. Serum Institute of India Pvt. Ltd. Recent Development
    Table 67. Johnson & Johnson Corporation Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. Johnson & Johnson Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. Astellas Pharma Inc. Corporation Information
    Table 73. Astellas Pharma Inc. Description and Business Overview
    Table 74. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 75. Astellas Pharma Inc. Product
    Table 76. Astellas Pharma Inc. Recent Development
    Table 77. Astrazeneca Plc. Corporation Information
    Table 78. Astrazeneca Plc. Description and Business Overview
    Table 79. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Astrazeneca Plc. Product
    Table 81. Astrazeneca Plc. Recent Development
    Table 82. CSL Limited Corporation Information
    Table 83. CSL Limited Description and Business Overview
    Table 84. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 85. CSL Limited Product
    Table 86. CSL Limited Recent Development
    Table 87. Emergent Biosolutions Corporation Information
    Table 88. Emergent Biosolutions Description and Business Overview
    Table 89. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 90. Emergent Biosolutions Product
    Table 91. Emergent Biosolutions Recent Development
    Table 92. Walvax Biotechnology Corporation Information
    Table 93. Walvax Biotechnology Description and Business Overview
    Table 94. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 95. Walvax Biotechnology Product
    Table 96. Walvax Biotechnology Recent Development
    Table 97. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
    Table 98. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
    Table 99. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 100. Royal (Wuxi) Bio-Pharmaceutical Product
    Table 101. Royal (Wuxi) Bio-Pharmaceutical Recent Development
    Table 102. Zhifei Biologic Corporation Information
    Table 103. Zhifei Biologic Description and Business Overview
    Table 104. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 105. Zhifei Biologic Product
    Table 106. Zhifei Biologic Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Pneumonia Vaccine Customers List
    Table 110. Pneumonia Vaccine Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pneumonia Vaccine Product Picture
    Figure 2. Global Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pneumonia Vaccine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Pneumonia Vaccine Sales 2017-2028 (K Doses)
    Figure 5. United States Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Pneumonia Vaccine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Pneumonia Vaccine Sales 2017-2028 (K Doses)
    Figure 8. United States Pneumonia Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Pneumonia Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Pneumonia Vaccine Report Years Considered
    Figure 11. Product Picture of Pneumococcal Conjugate Vaccine (PCV13)
    Figure 12. Product Picture of Pneumococcal Polysaccharide Vaccine (PPSV23)
    Figure 13. Product Picture of Other
    Figure 14. Global Pneumonia Vaccine Market Share by Type in 2022 & 2028
    Figure 15. Global Pneumonia Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Pneumonia Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Pneumonia Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 18. Global Pneumonia Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 20. United States Pneumonia Vaccine Market Share by Type in 2022 & 2028
    Figure 21. United States Pneumonia Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Pneumonia Vaccine Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Pneumonia Vaccine Sales by Type (2017-2028) & (K Doses)
    Figure 24. United States Pneumonia Vaccine Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose)
    Figure 26. Product Picture of Pneumonia
    Figure 27. Product Picture of Meningitis
    Figure 28. Product Picture of Sepsis
    Figure 29. Global Pneumonia Vaccine Market Share by Application in 2022 & 2028
    Figure 30. Global Pneumonia Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Pneumonia Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Pneumonia Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 33. Global Pneumonia Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 35. United States Pneumonia Vaccine Market Share by Application in 2022 & 2028
    Figure 36. United States Pneumonia Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Pneumonia Vaccine Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Pneumonia Vaccine Sales by Application (2017-2028) & (K Doses)
    Figure 39. United States Pneumonia Vaccine Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose)
    Figure 41. North America Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 42. North America Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 46. Europe Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 53. Asia-Pacific Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 65. Latin America Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 70. Middle East & Africa Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Pneumonia Vaccine Value Chain
    Figure 75. Pneumonia Vaccine Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed